September 5, 2018
(Reuters) – Embattled blood-testing company Theranos Inc will soon formally dissolve, the Wall Street Journal reported https://ift.tt/2LXL69B on Tuesday, citing a shareholder email.
The Silicon Valley firm will attempt to pay unsecured creditors its remaining cash in the coming months, the report said, adding that big name investors had lost about $1 billion.
Theranos founder Elizabeth Holmes and the company’s former president Ramesh “Sunny” Balwani were indicted in June on charges that they engaged in schemes to defraud investors, doctors and patients.
Prosecutors had said Holmes and Balwani used advertising and solicitations to encourage doctors and patients to use its blood testing laboratory services despite knowing the company could not produce accurate and reliable results consistently.
Theranos did not immediately respond to Reuters’ request for comment.
(Reporting by Kanishka Singh in Bengaluru; Editing by Sai Sachin Ravikumar)
The post Embattled blood-testing firm Theranos to dissolve: WSJ appeared first on One America News Network.
September 05, 2018 at 08:40AM
from One America News Network